相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
Amit G. Singal et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Improving Screening for Hepatocellular Carcinoma by Incorporating Data on Levels of α-Fetoprotein, Over Time
Elliot Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Accuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment
Grace Lai-Hung Wong et al.
GASTROENTEROLOGY (2013)
PERFORMANCE OF HEPATOCELLULAR CARCINOMA RISK SCORES IN CHRONIC HEPATITIS B PATIENTS RECEIVING ENTECAVIR TREATMENT
V. W. -S. Wong et al.
JOURNAL OF HEPATOLOGY (2013)
Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years
G. L. -H. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
Qiujin Shen et al.
LANCET ONCOLOGY (2012)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai-I Yang et al.
LANCET ONCOLOGY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Alpha-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2010)
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
Yilei Mao et al.
GUT (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
Vincent Wai-Sun Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B
Vincent Wai-Sun Wong et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
Man-Fung Yuen et al.
JOURNAL OF HEPATOLOGY (2009)
Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
J. J. Y. Sung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Design and endpoints of clinical trials in hepatocellular carcinoma
Josep M. Llovet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis
Grace Lai-Hung Wong et al.
LIVER INTERNATIONAL (2008)
Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients
Gianluigi Giannelli et al.
CLINICA CHIMICA ACTA (2007)
Hepatocellular carcinoma and hepatitis B virus
HLY Chan et al.
SEMINARS IN LIVER DISEASE (2006)
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
JA Marrero et al.
JOURNAL OF HEPATOLOGY (2005)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma
G Giannelli et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
AM Di Bisceglie et al.
JOURNAL OF HEPATOLOGY (2005)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients
JA Marrero et al.
HEPATOLOGY (2003)
Screening for liver cancer: results of a randomised controlled trial in Qidong, China
JG Chen et al.
JOURNAL OF MEDICAL SCREENING (2003)
Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation
HLY Chan et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America
MJ Tong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease:: influence of HBsAg and anti-HCV status
F Trevisani et al.
JOURNAL OF HEPATOLOGY (2001)
Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study
BJ McMahon et al.
HEPATOLOGY (2000)